Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 1
2004 1
2005 1
2007 3
2008 3
2009 3
2011 1
2012 5
2014 1
2015 3
2016 2
2017 5
2018 6
2019 1
2020 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Ral signaling pathway in health and cancer.
Moghadam AR, Patrad E, Tafsiri E, Peng W, Fangman B, Pluard TJ, Accurso A, Salacz M, Shah K, Ricke B, Bi D, Kimura K, Graves L, Najad MK, Dolatkhah R, Sanaat Z, Yazdi M, Tavakolinia N, Mazani M, Amani M, Ghavami S, Gartell R, Reilly C, Naima Z, Esfandyari T, Farassati F. Moghadam AR, et al. Among authors: farassati f. Cancer Med. 2017 Dec;6(12):2998-3013. doi: 10.1002/cam4.1105. Epub 2017 Oct 18. Cancer Med. 2017. PMID: 29047224 Free PMC article. Review.
The role of KPNβ1 in neuro-oncology.
Lilley M, Farassati F. Lilley M, et al. Among authors: farassati f. Onco Targets Ther. 2017 Apr 10;10:2067-2068. doi: 10.2147/OTT.S136247. eCollection 2017. Onco Targets Ther. 2017. PMID: 28435297 Free PMC article. No abstract available.
Cancer stem cells, the ultimate targets in cancer therapy.
Shabbir A, Esfandyari T, Farassati F. Shabbir A, et al. Among authors: farassati f. Onco Targets Ther. 2018 Jan 3;11:183-184. doi: 10.2147/OTT.S154431. eCollection 2018. Onco Targets Ther. 2018. PMID: 29379299 Free PMC article. No abstract available.
Targeting Cancer Stem Cells by Oncolytic Viruses and Nano-Mediated Delivery.
Hosseini M, Farassati FS, Farassati F. Hosseini M, et al. Among authors: farassati f, farassati fs. Onco Targets Ther. 2020 Sep 22;13:9349-9350. doi: 10.2147/OTT.S279639. eCollection 2020. Onco Targets Ther. 2020. PMID: 33061422 Free PMC article. No abstract available.
Oncolytic viruses and cancer therapy.
Norman KL, Farassati F, Lee PW. Norman KL, et al. Among authors: farassati f. Cytokine Growth Factor Rev. 2001 Jun-Sep;12(2-3):271-82. doi: 10.1016/s1359-6101(00)00024-1. Cytokine Growth Factor Rev. 2001. PMID: 11325607 Review. No abstract available.
Ezh2, a novel target in detection and therapy of breast cancer.
Pourakbar S, Pluard TJ, Accurso AD, Farassati F. Pourakbar S, et al. Among authors: farassati f. Onco Targets Ther. 2017 May 22;10:2685-2687. doi: 10.2147/OTT.S138777. eCollection 2017. Onco Targets Ther. 2017. PMID: 28579806 Free PMC article. No abstract available.
RalA is overactivated in medulloblastoma.
Ginn KF, Fangman B, Terai K, Wise A, Ziazadeh D, Shah K, Gartrell R, Ricke B, Kimura K, Mathur S, Borrego-Diaz E, Farassati F. Ginn KF, et al. Among authors: farassati f. J Neurooncol. 2016 Oct;130(1):99-110. doi: 10.1007/s11060-016-2236-4. Epub 2016 Aug 26. J Neurooncol. 2016. PMID: 27566179
Pro-oncogenic cell signaling machinery as a target for oncolytic viruses.
Borrego-Diaz E, Mathew R, Hawkinson D, Esfandyari T, Liu Z, Lee PW, Farassati F. Borrego-Diaz E, et al. Among authors: farassati f. Curr Pharm Biotechnol. 2012 Jul;13(9):1742-9. doi: 10.2174/138920112800958788. Curr Pharm Biotechnol. 2012. PMID: 21740363 Review.
39 results